Literature DB >> 10598604

Experimental pain augments experimental dyspnea, but not vice versa in human volunteers.

T Nishino1, N Shimoyama, T Ide, S Isono.   

Abstract

BACKGROUND: Pain and dyspnea frequently coexist in many clinical situations. However, whether the two different symptoms interact with each other has not been elucidated. To elucidate the interaction between pain and dyspneic sensations, the authors investigated separately the effects of pain on dyspnea and the effects of dyspnea on pain in 15 healthy subjects.
METHODS: Subjects were asked to rate their sensation of pain or dyspnea using a visual analog scale (VAS) during pain stimulation produced by tourniquet inflation (inflation cuff pressure: 350 mmHg) around the calf, and/or the respiratory loading consisted of a combination of resistive load (77 cm H2O x l(-1) x s(-1)) and hypercapnia induced by extra mechanical dead space (255 ml). In addition to changes in VAS scores, changes in ventilatory airflow and airway pressure were continuously measured.
RESULTS: Pain stimulation and loaded breathing increased VAS scores, ventilation, and occlusion pressure (P0.1). The addition of a pain stimulus during loaded breathing increased the dyspneic VAS score (median 56 [interquartile range 50-62] vs. 64 [55-77]: before vs. after addition of pain stimulus, P < 0.05) with concomitant increases in minute ventilation (10.8 [10.1-13.3] vs. 12.4 [11.0-14.8] l/min, P < 0.05) and P0.1 (5.5 [4.9-7.2] vs. 6.8 [5.8-9.0] cm H2O, P < 0.05). The addition of respiratory loading during pain stimulation did not cause a significant change in pain VAS score (40 [33-55] vs. 31 [30-44]: before vs. after addition of respiratory loading), although both additional burdens increased further minute ventilation (10.0 [8.8-10.9] vs. 12.0 [10.6-13.2] l/min, P < 0.05) and P0.1 (2.5 [2.0-3.0] vs. 6.2 [4.9-7.0] cm H2O, P < 0.05).
CONCLUSION: The authors' findings suggest that pain intensifies the dyspneic sensation, presumably by increasing the respiratory drive, whereas dyspnea may not intensify the pain sensation.

Entities:  

Mesh:

Year:  1999        PMID: 10598604     DOI: 10.1097/00000542-199912000-00014

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  Dyspnea and its interaction with pain.

Authors:  Takashi Nishino
Journal:  J Anesth       Date:  2010-12-14       Impact factor: 2.078

2.  Unique, common, and interacting cortical correlates of thirst and pain.

Authors:  Michael J Farrell; Gary F Egan; Frank Zamarripa; Robert Shade; John Blair-West; Peter Fox; Derek A Denton
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

3.  [Pulmonary causes of chest pain].

Authors:  B Jany
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

4.  A controlled trial of the effects of leg training on breathing pattern and dynamic hyperinflation in severe COPD.

Authors:  Luis Puente-Maestu; Yolanda Martinez Abad; Fernando Pedraza; Gemma Sánchez; William W Stringer
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

Review 5.  [Heart and lungs : cardinal symptom dyspnea].

Authors:  M O Henke; C F Vogelmeier
Journal:  Herz       Date:  2013-05       Impact factor: 1.443

6.  Dyspnea and pain frequently co-occur among Medicare managed care recipients.

Authors:  Nathan Clark; Vincent S Fan; Christopher G Slatore; Emily Locke; Heather E Whitson; Linda Nici; Stephen M Thielke
Journal:  Ann Am Thorac Soc       Date:  2014-07

Review 7.  Shrinking lung syndrome in systemic lupus erythematosus: A case series and review of the literature.

Authors:  Helena Borrell; Javier Narváez; Juan José Alegre; Ivan Castellví; Francesca Mitjavila; María Aparicio; Eulàlia Armengol; María Molina-Molina; Joan M Nolla
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

8.  Predicting opioid dependence from electronic health records with machine learning.

Authors:  Randall J Ellis; Zichen Wang; Nicholas Genes; Avi Ma'ayan
Journal:  BioData Min       Date:  2019-01-29       Impact factor: 2.522

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.